23 results

• FDA Issues Draft Guidance On Conducting Safety Trials For New Diabetes Drugs

  March 12, 2020

  Russell Maas

  A draft guidance seeks to require broader clinical trials for diabetes drugs, in an effort to better identify potential adverse health effects before they receive FDA approval.

• Some Diabetes Drugs Side Effects May Have Toxic Effects On Mitochondria, Causing Heart Problems: Study

  September 26, 2019

  Martha Garcia

  A new study indicates diabetes drugs like Avandia may cause heart problems through mitochondrial toxicity, which could be preventable through the use of other medications.

• Report Reveals Some FDA Advisors Have Undisclosed Financial Ties

  December 11, 2014

  Staff Writers

  A new report raises concerns that the FDA is revealing only a fraction of the potential conflicts of interest on its advisory boards.

• Proteins May Be Key To Identifying New Drug Side Effects: Study

  November 4, 2014

  Irvin Jackson

  A new study shows that computer modeling could link some drug side effects to certain proteins, allowing drug companies and the FDA to detect more possible adverse event risks before drugs get to consumers.

• Metformin Has No Heart Benefits For Non-Diabetics: JAMA

  December 31, 2013

  Irvin Jackson

  A medical journal finds that collected data indicates that metformin cannot be used to decrease heart risk in people without diabetes.

• Metformin May Increase Heart Failure Risk in Men: Study

  December 20, 2013

  Irvin Jackson

  The diabetes drug Metformin appears to affect men and women's hearts differently, according to a new study that raises questions about gender differences in a number of diabetes drugs.

• Sulphonylurea Diabetes Drugs May Increase Heart Attack Risk: Study

  September 19, 2013

  Irvin Jackson

  An older class of diabetes drugs has been linked to heart problems following a clincal study to confirm long-held fears.

• New J&J Medication, Invokana, Hopes To Break Diabetes Drug Curse

  April 11, 2013

  Irvin Jackson

  Johnson & Johnson has high hopes that its recently approved diabetes drug, Invokana, will break the trend of problems that...

• Appeals Court Calls Off-Label Drug Marketing Free Speech

  December 7, 2012

  Irvin Jackson

  In a decision that could fundamentally change the actions of the pharmaceutical industry in the United States, a federal appeals...

• FDA Should Define Role in Protecting Clinical Trial Participants: Report

  August 24, 2012

  Martha Garcia

  Researchers are calling for federal regulators to take a new look at the ethics behind post-marketing trials, which often involve...